# The Combined Effect of N-Acetyl Cysteine and Metformin in Polycystic Ovary Syndrome Patients

> **NCT06836128** · PHASE3 · RECRUITING · sponsor: **Cairo University** · enrollment: 102 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** N-acetyl cysteine
- **DRUG:** Metfomin

## Key facts

- **NCT ID:** NCT06836128
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2026-02-01
- **Final completion:** 2026-05-01
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2025-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06836128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06836128, "The Combined Effect of N-Acetyl Cysteine and Metformin in Polycystic Ovary Syndrome Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06836128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*